探讨胆道支架联合125Ⅰ粒子植入术治疗肝门区肿瘤合并梗阻性黄疸的疗效  

Objective To Investigate the Effect of Biliary Stent Combined with 125Ⅰ Seed Implantation in the Treatment of Hilar Tumor with Obstructive Jaundice

作　　者：曾宇[1] 李珉 ZENG Yu;LI Min(Department of Surgery,Tianjin First Hospital,Tianjin 300232)

机构地区：[1]天津市第一医院外科

出　　处：《中国医疗器械信息》2020年第2期86-86,124,共2页China Medical Device Information

摘　　要：目的:研究胆道支架联合125I粒子植入术治疗肝门区肿瘤合并梗阻性黄疸的疗效。方法:选取本院于2018年1月~2019年1月收治的肝门区肿瘤合并梗阻性黄疸患者110例,按照治疗方案分为对照组(n=55例)和观察组(n=55例),对照组应用胆道支架治疗方案,观察组应用胆道支架联合125I粒子植入术治疗方案,对比分析两组患者的治疗效果。结果:观察组治疗总有效率高于对照组,且支架平均生存时间长于对照组(P<0.05)。结论:针对肝门区肿瘤合并梗阻性黄疸采取胆道支架联合125I粒子植入术治疗效果显著,能够有效缓解患者临床症状,延长患者的生存时间,有助于提高患者生存质量,在临床上具有应用价值。Objective:To study the curative effect of biliary stent combined with 125I seed implantation in the treatment of hilar area tumor with obstructive jaundice.Methods:A total of 110 patients with hepatic hilar tumors and obstructive jaundice treated in our hospital from January 2018 to January 2019 were selected and divided into control group(n=55 cases)and observation group(n=55 cases)according to the treatment plan.),The control group was treated with a biliary stent,and the observation group was treated with a biliary stent combined with 125I particle implantation.The treatment effects of the two groups were compared and analyzed.Results:The total effective rate of treatment in the observation group was higher than that in the control group,and the average survival time of the stent was longer than that in the control group(P<0.05).Conclusion:Biliary stent combined with 125I seed implantation for hepatic hilar tumors with obstructive jaundice is effective in treating patients with clinical symptoms,prolonging the survival time of patients,and helping to improve the quality of life of patients.value.

关 键 词：胆道支架 125I 粒子植入术 肝门区肿瘤 梗阻性黄疸 

分 类 号：R817.8[医药卫生—影像医学与核医学]